QNRX - מכפיל P/S Quoin Pharma

לוגו תאגידי של חברת quoinpharma.com (QNRX)

Quoin Pharmaceuticals (QNRX) is developing a unique therapy system for rare skin pathologies, creating irreplaceable treatment methods. The management team is currently optimizing patient selection under budget constraints. The price-to-sales ratio on the GURU.Markets chart reflects the market consensus, with the latest reading at . The orphan drug status ensures high margins and a steady stream of free cash flow for the company.

QNRX מכפיל P/S Quoin Pharma (04.07.2022 - 15.11.2026)

Quoin Pharmaceuticals Ltd (QNRX) - פילוחי מדדים ודוחות פיננסיים

- שווי שוק ותחזית יעד של אנליסטים:
ניתוח פונדמנטלי של החברה:Quoin Pharma - QNRX
מוצרים מיוצרים של Quoin Pharmaceuticals Ltd.

For the biotechnology sector of Quoin Pharmaceuticals (QNRX), where asset value depends on regulatory approvals for skin medications, the P/S multiple reflects the market value of one dollar of revenue. This ratio correlates market capitalization with annual turnover, allowing for an assessment of whether the business is overvalued or undervalued through the company's normalized P/S.